Build Your Comparison

Side-by-side financial analysis
USCB logo
USCB
NDAQ logo
NDAQ
JPM logo
JPM
ICE logo
ICE
CME logo
CME
Try popular comparisons:

Stock Comparison

USCB vs NDAQ vs JPM vs ICE vs CME

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
USCB
USCB Financial Holdings, Inc.

Banks - Regional

Financial ServicesNASDAQ • US
Market Cap$357M
5Y Perf.+83.6%
NDAQ
Nasdaq, Inc.

Financial - Data & Stock Exchanges

Financial ServicesNASDAQ • US
Market Cap$50.58B
5Y Perf.+43.0%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$896.00B
5Y Perf.+111.3%
ICE
Intercontinental Exchange, Inc.

Financial - Data & Stock Exchanges

Financial ServicesNYSE • US
Market Cap$79.60B
5Y Perf.+17.3%
CME
CME Group Inc.

Financial - Data & Stock Exchanges

Financial ServicesNASDAQ • US
Market Cap$97.79B
5Y Perf.+27.1%

USCB vs NDAQ vs JPM vs ICE vs CME — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
USCB logoUSCB
NDAQ logoNDAQ
JPM logoJPM
ICE logoICE
CME logoCME
IndustryBanks - RegionalFinancial - Data & Stock ExchangesBanks - DiversifiedFinancial - Data & Stock ExchangesFinancial - Data & Stock Exchanges
Market Cap$357M$50.58B$896.00B$79.60B$97.79B
Revenue (TTM)$152M$8.27B$280.33B$12.64B$6.76B
Net Income (TTM)$26M$1.91B$57.05B$3.30B$4.24B
Gross Margin58.1%54.8%60.0%61.9%86.3%
Operating Margin23.6%29.5%25.9%38.7%65.6%
Forward P/E9.8x22.6x14.4x17.3x22.0x
Total Debt$91M$9.93B$942.38B$20.28B$3.76B
Cash & Equiv.$82M$814M$343.34B$837M$4.42B

USCB vs NDAQ vs JPM vs ICE vs CMELong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

USCB
NDAQ
JPM
ICE
CME
StockJul 21Jun 26Return
USCB Financial Hold… (USCB)100183.6+83.6%
Nasdaq, Inc. (NDAQ)100143.0+43.0%
JPMorgan Chase & Co. (JPM)100211.3+111.3%
Intercontinental Ex… (ICE)100117.3+17.3%
CME Group Inc. (CME)100127.1+27.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: USCB vs NDAQ vs JPM vs ICE vs CME

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: NDAQ leads in 3 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and profitability and margin quality. USCB Financial Holdings, Inc. is the stronger pick specifically for valuation and capital efficiency. JPM, ICE, and CME also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
🥇NDAQ emerged as the overall leader. Track its performance:
USCB
USCB Financial Holdings, Inc.
The Banking Pick

USCB is the #2 pick in this set and the best alternative if valuation efficiency and bank quality is your priority.

  • PEG 0.38 vs NDAQ's 2.12
  • NIM 3.0% vs JPM's 2.2%
  • Lower P/E (9.8x vs 22.0x), PEG 0.38 vs 1.60
Best for: valuation efficiency and bank quality
NDAQ
Nasdaq, Inc.
The Banking Pick

NDAQ carries the broadest edge in this set and is the clearest fit for growth exposure.

  • Rev growth 11.1%, EPS growth 60.1%
  • 11.1% NII/revenue growth vs JPM's 3.3%
  • Efficiency ratio 0.2% vs USCB's 0.3% (lower = leaner)
  • Efficiency ratio 0.2% vs USCB's 0.3%
Best for: growth exposure
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM ranks third and is worth considering specifically for long-term compounding.

  • 465.8% 10Y total return vs NDAQ's 344.3%
  • +21.8% vs ICE's -20.4%
Best for: long-term compounding
ICE
Intercontinental Exchange, Inc.
The Banking Pick

ICE is the clearest fit if your priority is sleep-well-at-night and defensive.

  • Lower volatility, beta 0.35, Low D/E 69.9%, current ratio 1.02x
  • Beta 0.35, yield 1.4%, current ratio 1.02x
  • Beta 0.35 vs JPM's 0.94, lower leverage
Best for: sleep-well-at-night and defensive
CME
CME Group Inc.
The Banking Pick

CME is the clearest fit if your priority is income & stability.

  • Dividend streak 15 yrs, beta -0.28, yield 4.1%
  • 4.1% yield, 15-year raise streak, vs JPM's 1.9%
Best for: income & stability
See the full category breakdown
CategoryWinnerWhy
GrowthNDAQ logoNDAQ11.1% NII/revenue growth vs JPM's 3.3%
ValueUSCB logoUSCBLower P/E (9.8x vs 22.0x), PEG 0.38 vs 1.60
Quality / MarginsNDAQ logoNDAQEfficiency ratio 0.2% vs USCB's 0.3% (lower = leaner)
Stability / SafetyICE logoICEBeta 0.35 vs JPM's 0.94, lower leverage
DividendsCME logoCME4.1% yield, 15-year raise streak, vs JPM's 1.9%
Momentum (1Y)JPM logoJPM+21.8% vs ICE's -20.4%
Efficiency (ROA)NDAQ logoNDAQEfficiency ratio 0.2% vs USCB's 0.3%

USCB vs NDAQ vs JPM vs ICE vs CME — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

Discover the Fintech Stocks Theme

These companies are key players in the Fintech Stocks ecosystem. See how they stack up against the rest of the sector.

Explore Theme
USCBUSCB Financial Holdings, Inc.

Segment breakdown not available.

NDAQNasdaq, Inc.
FY 2025
Market Services
51.4%$4.2B
Capital Access Platforms
26.1%$2.1B
Market Technology
22.6%$1.9B
JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000
ICEIntercontinental Exchange, Inc.
FY 2025
Fixed Income And Data Services Segment
51.1%$1.4B
Exchanges Segment
38.8%$1.0B
Mortgage Technology Segment
10.1%$269M
CMECME Group Inc.
FY 2025
clearing and transaction fees
81.0%$5.3B
MarketData
12.3%$803M
OtherRevenue
6.7%$436M

USCB vs NDAQ vs JPM vs ICE vs CME — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCMELAGGINGICE

Income & Cash Flow (Last 12 Months)

CME leads this category, winning 4 of 5 comparable metrics.

JPM is the larger business by revenue, generating $280.3B annually — 1843.3x USCB's $152M. CME is the more profitable business, keeping 62.8% of every revenue dollar as net income compared to USCB's 17.2%.

MetricUSCB logoUSCBUSCB Financial Ho…NDAQ logoNDAQNasdaq, Inc.JPM logoJPMJPMorgan Chase & …ICE logoICEIntercontinental …CME logoCMECME Group Inc.
RevenueTrailing 12 months$152M$8.3B$280.3B$12.6B$6.8B
EBITDAEarnings before interest/tax$36M$3.1B$81.4B$6.5B$4.7B
Net IncomeAfter-tax profit$26M$1.9B$57.0B$3.3B$4.2B
Free Cash FlowCash after capex$43M$2.0B$100.9B$4.3B$4.4B
Gross MarginGross profit ÷ Revenue+58.1%+54.8%+60.0%+61.9%+86.3%
Operating MarginEBIT ÷ Revenue+23.6%+29.5%+25.9%+38.7%+65.6%
Net MarginNet income ÷ Revenue+17.2%+23.1%+20.4%+26.1%+62.8%
FCF MarginFCF ÷ Revenue+27.9%+24.2%+36.0%+33.9%+64.4%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year-79.4%+33.8%+16.0%+23.1%+21.4%
CME leads this category, winning 4 of 5 comparable metrics.

Valuation Metrics

USCB leads this category, winning 7 of 7 comparable metrics.

At 15.0x trailing earnings, USCB trades at a 48% valuation discount to NDAQ's 28.8x P/E. Adjusting for growth (PEG ratio), USCB offers better value at 0.58x vs ICE's 2.74x — a lower PEG means you pay less per unit of expected earnings growth.

MetricUSCB logoUSCBUSCB Financial Ho…NDAQ logoNDAQNasdaq, Inc.JPM logoJPMJPMorgan Chase & …ICE logoICEIntercontinental …CME logoCMECME Group Inc.
Market CapShares × price$357M$50.6B$896.0B$79.6B$97.8B
Enterprise ValueMkt cap + debt − cash$365M$59.7B$1.50T$99.0B$97.1B
Trailing P/EPrice ÷ TTM EPS15.04x28.80x16.00x24.36x24.15x
Forward P/EPrice ÷ next-FY EPS est.9.76x22.60x14.40x17.34x21.98x
PEG RatioP/E ÷ EPS growth rate0.58x2.69x0.90x2.74x1.76x
EV / EBITDAEnterprise value multiple10.04x20.14x18.36x15.34x21.56x
Price / SalesMarket cap ÷ Revenue2.35x6.15x3.20x6.30x15.00x
Price / BookPrice ÷ Book value/share1.69x4.19x2.47x2.77x3.38x
Price / FCFMarket cap ÷ FCF8.40x25.43x8.88x18.56x23.32x
USCB leads this category, winning 7 of 7 comparable metrics.

Profitability & Efficiency

CME leads this category, winning 4 of 9 comparable metrics.

JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $12 for ICE. CME carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), NDAQ scores 9/9 vs CME's 5/9, reflecting strong financial health.

MetricUSCB logoUSCBUSCB Financial Ho…NDAQ logoNDAQNasdaq, Inc.JPM logoJPMJPMorgan Chase & …ICE logoICEIntercontinental …CME logoCMECME Group Inc.
ROE (TTM)Return on equity+11.9%+15.9%+15.9%+11.6%+15.3%
ROA (TTM)Return on assets+1.0%+6.4%+1.3%+2.3%+2.2%
ROICReturn on invested capital+7.8%+8.1%+4.5%+7.5%+10.2%
ROCEReturn on capital employed+10.8%+10.2%+8.9%+9.5%+3.6%
Piotroski ScoreFundamental quality 0–969595
Debt / EquityFinancial leverage0.43x0.81x2.60x0.70x0.13x
Net DebtTotal debt minus cash$8M$9.1B$599.0B$19.4B-$666M
Cash & Equiv.Liquid assets$82M$814M$343.3B$837M$4.4B
Total DebtShort + long-term debt$91M$9.9B$942.4B$20.3B$3.8B
Interest CoverageEBIT ÷ Interest expense0.58x14.11x0.74x6.53x41.55x
CME leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

JPM leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $13,085 for ICE. Over the past 12 months, JPM leads with a +21.8% total return vs ICE's -20.4%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs ICE's 10.4% — a key indicator of consistent wealth creation.

MetricUSCB logoUSCBUSCB Financial Ho…NDAQ logoNDAQNasdaq, Inc.JPM logoJPMJPMorgan Chase & …ICE logoICEIntercontinental …CME logoCMECME Group Inc.
YTD ReturnYear-to-date+8.8%-7.3%-0.5%-11.8%+3.2%
1-Year ReturnPast 12 months+20.6%+4.0%+21.8%-20.4%+3.6%
3-Year ReturnCumulative with dividends+97.7%+80.8%+138.2%+34.6%+67.9%
5-Year ReturnCumulative with dividends+88.5%+60.2%+118.2%+30.9%+46.2%
10-Year ReturnCumulative with dividends+88.5%+344.3%+465.8%+195.3%+262.4%
CAGR (3Y)Annualised 3-year return+25.5%+21.8%+33.6%+10.4%+18.9%
JPM leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — JPM and CME each lead in 1 of 2 comparable metrics.

CME is the less volatile stock with a -0.28 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 95.1% from its 52-week high vs ICE's 74.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricUSCB logoUSCBUSCB Financial Ho…NDAQ logoNDAQNasdaq, Inc.JPM logoJPMJPMorgan Chase & …ICE logoICEIntercontinental …CME logoCMECME Group Inc.
Beta (5Y)Sensitivity to S&P 5000.70x0.71x0.94x0.35x-0.28x
52-Week HighHighest price in past year$20.79$101.79$337.25$189.35$329.16
52-Week LowLowest price in past year$15.57$77.09$262.71$136.67$244.56
% of 52W HighCurrent price vs 52-week peak+94.1%+87.4%+95.1%+74.2%+81.9%
RSI (14)Momentum oscillator 0–10063.241.259.131.940.1
Avg Volume (50D)Average daily shares traded58K3.0M7.0M3.2M2.6M
Evenly matched — JPM and CME each lead in 1 of 2 comparable metrics.

Analyst Outlook

CME leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: USCB as "Buy", NDAQ as "Buy", JPM as "Buy", ICE as "Buy", CME as "Hold". Consensus price targets imply 38.0% upside for ICE (target: $194) vs 5.9% for JPM (target: $340). For income investors, CME offers the higher dividend yield at 4.05% vs NDAQ's 1.17%.

MetricUSCB logoUSCBUSCB Financial Ho…NDAQ logoNDAQNasdaq, Inc.JPM logoJPMJPMorgan Chase & …ICE logoICEIntercontinental …CME logoCMECME Group Inc.
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuyHold
Price TargetConsensus 12-month target$24.00$113.83$339.75$194.00$320.80
# AnalystsCovering analysts336613636
Dividend YieldAnnual dividend ÷ price+2.2%+1.2%+1.9%+1.4%+4.1%
Dividend StreakConsecutive years of raises214151315
Dividend / ShareAnnual DPS$0.43$1.04$5.95$1.93$10.92
Buyback YieldShare repurchases ÷ mkt cap+9.7%+1.2%+3.9%+1.7%+0.3%
CME leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

CME leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). USCB leads in 1 (Valuation Metrics). 1 tied.

Best OverallCME Group Inc. (CME)Leads 3 of 6 categories
Loading custom metrics...

USCB vs NDAQ vs JPM vs ICE vs CME: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is USCB or NDAQ or JPM or ICE or CME a better buy right now?

For growth investors, Nasdaq, Inc.

(NDAQ) is the stronger pick with 11. 1% revenue growth year-over-year, versus 3. 3% for JPMorgan Chase & Co. (JPM). USCB Financial Holdings, Inc. (USCB) offers the better valuation at 15. 0x trailing P/E (9. 8x forward), making it the more compelling value choice. Analysts rate USCB Financial Holdings, Inc. (USCB) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — USCB or NDAQ or JPM or ICE or CME?

On trailing P/E, USCB Financial Holdings, Inc.

(USCB) is the cheapest at 15. 0x versus Nasdaq, Inc. at 28. 8x. On forward P/E, USCB Financial Holdings, Inc. is actually cheaper at 9. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: USCB Financial Holdings, Inc. wins at 0. 38x versus Nasdaq, Inc. 's 2. 12x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — USCB or NDAQ or JPM or ICE or CME?

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +118. 2%, compared to +30. 9% for Intercontinental Exchange, Inc. (ICE). Over 10 years, the gap is even starker: JPM returned +465. 8% versus USCB's +88. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — USCB or NDAQ or JPM or ICE or CME?

By beta (market sensitivity over 5 years), CME Group Inc.

(CME) is the lower-risk stock at -0. 28β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately -435% more volatile than CME relative to the S&P 500. On balance sheet safety, CME Group Inc. (CME) carries a lower debt/equity ratio of 13% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

05

Which is growing faster — USCB or NDAQ or JPM or ICE or CME?

By revenue growth (latest reported year), Nasdaq, Inc.

(NDAQ) is pulling ahead at 11. 1% versus 3. 3% for JPMorgan Chase & Co. (JPM). On earnings-per-share growth, the picture is similar: Nasdaq, Inc. grew EPS 60. 1% year-over-year, compared to 1. 5% for JPMorgan Chase & Co.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — USCB or NDAQ or JPM or ICE or CME?

CME Group Inc.

(CME) is the more profitable company, earning 62. 0% net margin versus 17. 2% for USCB Financial Holdings, Inc. — meaning it keeps 62. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CME leads at 64. 9% versus 23. 6% for USCB. At the gross margin level — before operating expenses — CME leads at 86. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is USCB or NDAQ or JPM or ICE or CME more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, USCB Financial Holdings, Inc. (USCB) is the more undervalued stock at a PEG of 0. 38x versus Nasdaq, Inc. 's 2. 12x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, USCB Financial Holdings, Inc. (USCB) trades at 9. 8x forward P/E versus 22. 6x for Nasdaq, Inc. — 12. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ICE: 38. 0% to $194. 00.

08

Which pays a better dividend — USCB or NDAQ or JPM or ICE or CME?

All stocks in this comparison pay dividends.

CME Group Inc. (CME) offers the highest yield at 4. 1%, versus 1. 2% for Nasdaq, Inc. (NDAQ).

09

Is USCB or NDAQ or JPM or ICE or CME better for a retirement portfolio?

For long-horizon retirement investors, CME Group Inc.

(CME) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 28), 4. 1% yield, +262. 4% 10Y return). Both have compounded well over 10 years (CME: +262. 4%, USCB: +88. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between USCB and NDAQ and JPM and ICE and CME?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: USCB is a small-cap deep-value stock; NDAQ is a mid-cap quality compounder stock; JPM is a large-cap deep-value stock; ICE is a mid-cap quality compounder stock; CME is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.